Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
PUT
Perrigo
PRGO
$1.96B
| $80.3M | 0.04% |
869,400
-148,000
| -15% | -$13.6M |
|
|
STJ
377
PUT
DELISTED
St Jude Medical
STJ
| $79.2M | 0.04% |
992,400
+912,800
| +1,147% | +$73.7M |
|
378
CALL
Cigna
CI
$73.6B
| $79.1M | 0.04% |
607,000
+111,600
| +23% | +$14.6M |
|
379
PUT
Wheaton Precious Metals
WPM
$72.3B
| $79M | 0.04% |
2,922,500
+960,400
| +49% | +$26.4M |
|
|
380
Wheaton Precious Metals
WPM
$72.3B
| $79M | 0.04% |
2,921,014
+1,107,128
| +61% | +$30.5M |
|
381
PUT
Mastercard
MA
$523B
| $79M | 0.04% |
775,800
-295,200
| -28% | -$28.3M |
|
382
CALL
Oracle
ORCL
$412B
| $78.9M | 0.04% |
2,008,300
-868,900
| -30% | -$35.4M |
|
383
PUT
JD.com
JD
$39.4B
| $78.3M | 0.04% |
3,002,400
-594,300
| -17% | -$14.3M |
|
384
Bausch Health
BHC
$2.43B
| $78.1M | 0.04% |
3,179,888
-2,062,882
| -39% | -$53.4M |
|
385
T-Mobile US
TMUS
$197B
| $78M | 0.04% |
1,669,262
+647,625
| +63% | +$29.7M |
|
|
AET
386
PUT
DELISTED
Aetna Inc
AET
| $77.9M | 0.04% |
674,500
-195,200
| -22% | -$22.9M |
|
387
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
| $77M | 0.04% |
3,988,800
-4,505,698
| -53% | -$92.9M |
|
388
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$361M
| $76.9M | 0.04% |
702,800
-106,700
| -13% | -$11.6M |
|
|
ICPT
389
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $76.4M | 0.04% |
464,300
-53,400
| -10% | -$8.42M |
|
390
CALL
Hilton Worldwide
HLT
$74.2B
| $75.2M | 0.04% |
1,093,267
+925,267
| +551% | +$65.3M |
|
391
CALL
Western Digital
WDC
$155B
| $75M | 0.04% |
1,696,615
-1,013,286
| -37% | -$38.2M |
|
392
CALL
Ford
F
$55.1B
| $74.9M | 0.04% |
6,205,000
-1,988,700
| -24% | -$25.1M |
|
393
PUT
Abbott
ABT
$202B
| $74.7M | 0.04% |
1,765,300
+332,300
| +23% | +$14.2M |
|
394
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$461M
| $74.5M | 0.04% |
782,300
+139,800
| +22% | +$13.2M |
|
395
CALL
APA Corp
APA
$14.7B
| $74.1M | 0.04% |
1,160,800
+213,600
| +23% | +$11.7M |
|
396
CALL
Prudential Financial
PRU
$42B
| $74.1M | 0.04% |
907,500
-512,300
| -36% | -$39.3M |
|
397
PUT
Target
TGT
$77.4B
| $73.8M | 0.04% |
1,074,500
-537,300
| -33% | -$38.5M |
|
398
CALL
Kraft Heinz
KHC
$30.5B
| $73.6M | 0.04% |
822,800
-1,672,900
| -67% | -$148M |
|
399
Chipotle Mexican Grill
CMG
$48.1B
| $73.2M | 0.04% |
8,643,450
-13,072,950
| -60% | -$107M |
|
|
GWPH
400
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $73.2M | 0.04% |
551,300
+138,900
| +34% | +$13.3M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.